Broader Metabolic Benefits Reduces systemic inflammation Enhances mitochondrial health Improves insulin resistance Supports healthy aging How MOTS-c Compares to Other Peptides Ideal Candidates for MOTS-c Central obesity or visceral fat Prediabetes or insulin resistance Metabolic syndrome Aging with muscle loss or fatigue Poor mitochondrial function Clinical Use Best used in cycles (e.g., 8 weeks on, 4 weeks off) Monitor: IGF-1, glucose, CRP, lipid panel, DEXA scan Integration into a Metabolic Plan Combine MOTS-c with: Anti-inflammatory diet Intermittent fasting Resistance and aerobic training CJC-1295, Ipamorelin, or Tesamorelin for synergistic effects Is MOTS-c Safe
If children miss a dose of TRESIBA: Call the healthcare provider for information and instructions about checking blood sugar levels more often until the next scheduled dose of TRESIBA
Gordon H, Burisch J, Ellul P, et al
10.1016/0165-1781(96)02862-4 Psychiatry Res
PMID: 64 NagashimaRKosaiHMasuoMIzumiyamaKNoshikawajiTMorimotoMet al
The arrival of orforglipron represents a significant step toward making effective weight management accessible to a broader population
